TGM-312-SC01

· Tangram Therapeutics Plc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TGM-312-SC01, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of TGM-312-SC01 in Healthy Participants and Adults With MASH [Phase 1, Phase 2]